中文

东星医疗 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-21
ItemAmountY/Y
Revenue¥0.09B+15.7%
Gross profit¥0.05B
Operating income¥0.02B
Net income¥0.02B+50.1%
Gross margin50.2%Net margin 19.4%
Revenue Q/Q-12.8%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.05B49.8%
R&D¥0.00B5.1%
SG&A¥0.03B27.7%
Tax & other¥0.00B4.4%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

明阳电气海科新源三博脑科美硕科技新巨丰富乐德东利机械卓创资讯远翔新材川宁生物华如科技真兰仪表

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies